Telemus Capital’s West Pharmaceutical WST Stock Holding History

Telemus Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,576	Closed	-$460K	–	444
2020 Q3	$460K	Buy	+1,576	New	+$417K	0.03%	315

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Telemus Capital's WST Position: Q4 2020 in Review

Telemus Capital sold out of West Pharmaceutical (WST) in Q4 2020, closing a stake of 1,576 shares — an estimated $460K sold.

Telemus Capital first reported a position in WST in Q3 2020 and held it in 1 quarter. The position peaked at $460K in Q3 2020. 592 funds tracked by Wall St. Rank hold WST as of Q4 2020.

Telemus Capital reported no remaining West Pharmaceutical position as of Q4 2020 after selling out during the quarter.
Telemus Capital sold 1,576 West Pharmaceutical shares in Q4 2020, an estimated $460K.
Telemus Capital first reported a position in West Pharmaceutical in Q3 2020 and held it in 1 quarter.
Telemus Capital's West Pharmaceutical position peaked at $460K in Q3 2020.
592 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2020.

Based on Telemus Capital's 13F filing for Q4 2020, filed 28 Jan 2021.